TS Financial Group (TSFG)’s Celldex Therapeutics CLDX Stock Holding History
Bought
Maintained
Sold
Other funds holding CLDX
KCM
BBA
TS Financial Group (TSFG)'s CLDX Position: Q3 2026 in Review
TS Financial Group (TSFG) sold out of Celldex Therapeutics (CLDX) in Q3 2026, closing a stake of 50 shares — an estimated $2K sold.
TS Financial Group (TSFG) first reported a position in CLDX in Q2 2021 and held it in 21 quarters. The position peaked at $5K in Q3 2021. 249 funds tracked by Wall St. Rank hold CLDX as of Q3 2026.
- TS Financial Group (TSFG) reported no remaining Celldex Therapeutics position as of Q3 2026 after selling out during the quarter.
- TS Financial Group (TSFG) sold 50 Celldex Therapeutics shares in Q3 2026, an estimated $2K.
- TS Financial Group (TSFG) first reported a position in Celldex Therapeutics in Q2 2021 and held it in 21 quarters.
- TS Financial Group (TSFG)'s Celldex Therapeutics position peaked at $5K in Q3 2021.
- 249 funds tracked by Wall St. Rank held Celldex Therapeutics as of Q3 2026.
Based on TS Financial Group (TSFG)'s 13F filing for Q3 2026, filed 23 Oct 2026.